Ilkka Jussila

Tutkija
³Û°ì²õ¾±°ì°ìö
Liikuntatieteellinen tiedekunta
³§Ã¤³ó°ìö±è´Ç²õ³Ù¾±
ilkka.a.jussila@jyu.fi

Julkaisut

Julkaisu
2025

Scandinavian Journal of Medicine and Science in Sports.
Rantaniemi, Lauri
Jussila, Ilkka
Siltari, Aino
Ahtiainen, Juha P.
Hakulinen, Annastiina
Harju, Eeva
Sormunen, Jorma
Nordström, Tupu
Tammela, Teuvo L. J.
Murtola, Teemu J.
Julkaisu
2025

Duodecim.
Murtola, Teemu
Siltari, Aino
Jussila, Ilkka
Seikkula, Heikki
Minn, Heikki
Karihtala, Peeter
Sormunen
Jorma
Julkaisu
2025

BJUI Compass.
Jussila, Ilkka
Ahtiainen, Juha P.
Laakkonen, Eija K.
Käkelä, Pirjo
Parviainen, Maisa
Pohjolainen, Heikki
Aaltonen, Jarno
Onni, Ninamaria
Mikko, Koskimaa
Murtola, Teemu J.
Huhtala, Heini
Seikkula, Heikki
Julkaisu
2024

European Journal of Applied Physiology.
Gomez-Guerrero, Gonzalo
Avela, Janne
Jussila, Ilkka
Pihlajamäki, Esa
Deng, Fu-Yu
Kidgell, Dawson J.
Ahtiainen, Juha P.
Walker, Simon
Julkaisu
2024

BJU International.
Jussila, Ilkka
Ahtiainen, Juha P.
Laakkonen, Eija K.
Siltari, Aino
Kaipia, Antti
Jokela, Tiina
Kärkkäinen, Minta
Newton, Rob
Raastad, Truls
Huhtala, Heini
Murtola, Teemu J.
Seikkula, Heikki

Hankkeet

tradere_picture
Hanke

TraDeRe (Resistance TRAining, DEtraining, and REtraining)

The TraDeRe2 project investigates intra- and inter-individual variation in resistance training responses. The aim is to identify the determinants of individual variation in resistance training, detraining and retraining.
ESTRACISE
Hanke

Transdermal estradiol and exercise in mitigating adverse effects of androgen deprivation therapy for prostate cancer radiation therapy (ESTRACISE): Randomized controlled trial

ESTRACISE is a phase IIa open-label randomized controlled trial. The goal is to evaluate the effectiveness of transdermal estradiol with or without resistance training to mitigate the adverse effects of androgen deprivation therapy.